Email not displaying correctly? View it in your browser.
Forefront
   Volume 2, Issue 4, December 2013
Follow us:   Facebook icon Twitter icon Youtube icon  
 
 
Robert B. Diasio, M.D Director's message: Celebrating a year of research discoveries

See highlights from the Mayo Clinic Cancer Center's accomplishments in 2013.

 

  Features
Research

Brain cancer survival improves after FDA approval of bevacizumab

Treatment strategies involving bevacizumab prolonged survival in patients with progressive glioblastoma

Research

Researchers decode origin of inflammation-driven pancreatic cancer

Findings point to ways to identify patients at risk of pancreatic cancer and potential drug therapies that might reverse the process.

Research

Mayo Clinic genomic analysis lends insight to prostate cancer

Prostate cancer tumors that are more aggressive have similar genetic origins, which may help in predicting cancer progression.

Research

Research team uncovers root cause of multiple myeloma relapse

An intrinsic resistance found in immature tumor progenitor cells causes the disease and spawns relapse.

Research

Meet the investigator: Tufia C. Haddad, M.D.

Dr. Haddad's research explores breast cancer, including experimental therapeutics, clinical trials and survivorship.

Research

Latest print edition of Forefront now available

Read the new issue of Forefront online and subscribe to receive your own complimentary copy.

Important Links


Comments Comments?
We're interested in your feedback about this email.
Print Edition Want the Print Edition?
A print edition of Forefront is published annually. To request a free subscription, send your name and mailing address to forefrontmagazine@mayo.edu.
Mayo Clinic
Cancer Center


13400 E. Shea Blvd.
Scottsdale, AZ 85259

4500 San Pablo Road
Jacksonville, FL 32224

200 First Street SW
Rochester, MN 55905


 

Newsletter Archive | Contact Mayo Clinic Cancer Center

© 2013 Mayo Foundation for Medical Education and Research,
200 First Street SW, Rochester, MN 55905.
All rights reserved.
Terms of Use